Home

Trevi Therapeutics, Inc. - Common Stock (TRVI)

4.2100
+0.1300 (3.19%)

Trevi Therapeutics Inc is a biopharmaceutical company focused on developing innovative therapies for chronic conditions with high unmet medical needs

The company's primary focus is on utilizing its proprietary formulation technology to create treatments for neurological and chronic pain disorders, including pruritus associated with specific dermatological conditions. Through advanced research and clinical trials, Trevi aims to bring new, effective solutions to patients suffering from debilitating symptoms, thereby improving their quality of life.

SummaryNewsPress ReleasesChartHistoricalFAQ

Frequently Asked Questions

Is Trevi Therapeutics, Inc. - Common Stock publicly traded?
Yes, Trevi Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Trevi Therapeutics, Inc. - Common Stock trade on?
Trevi Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Trevi Therapeutics, Inc. - Common Stock?
The ticker symbol for Trevi Therapeutics, Inc. - Common Stock is TRVI on the Nasdaq Stock Market
What is the current price of Trevi Therapeutics, Inc. - Common Stock?
The current price of Trevi Therapeutics, Inc. - Common Stock is 4.210
When was Trevi Therapeutics, Inc. - Common Stock last traded?
The last trade of Trevi Therapeutics, Inc. - Common Stock was at 4:00 pm EST on February 5th, 2025
What is the market capitalization of Trevi Therapeutics, Inc. - Common Stock?
The market capitalization of Trevi Therapeutics, Inc. - Common Stock is 252.89M
How many shares of Trevi Therapeutics, Inc. - Common Stock are outstanding?
Trevi Therapeutics, Inc. - Common Stock has 60.07M shares outstanding.